179 related articles for article (PubMed ID: 11230491)
21. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
22. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
23. Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Goodwin JS
J Clin Oncol; 2006 Jun; 24(18):2750-6. PubMed ID: 16782915
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of radiation therapy for older women with early breast cancer.
Smith BD; Gross CP; Smith GL; Galusha DH; Bekelman JE; Haffty BG
J Natl Cancer Inst; 2006 May; 98(10):681-90. PubMed ID: 16705122
[TBL] [Abstract][Full Text] [Related]
26. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
27. The use of breast conserving surgery: linking insurance claims with tumor registry data.
Maskarinec G; Dhakal S; Yamashiro G; Issell BF
BMC Cancer; 2002; 2():3. PubMed ID: 11879527
[TBL] [Abstract][Full Text] [Related]
28. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
Heck JE; Albert SM; Franco R; Gorin SS
J Am Geriatr Soc; 2008 Sep; 56(9):1687-92. PubMed ID: 18691280
[TBL] [Abstract][Full Text] [Related]
29. Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.
Lang K; Hao Y; Huang H; Lin I; Rogerio JW; Menzin J
J Comp Eff Res; 2014 Sep; 3(5):481-90. PubMed ID: 25350800
[TBL] [Abstract][Full Text] [Related]
30. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
31. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
Hassett MJ; O'Malley AJ; Pakes JR; Newhouse JP; Earle CC
J Natl Cancer Inst; 2006 Aug; 98(16):1108-17. PubMed ID: 16912263
[TBL] [Abstract][Full Text] [Related]
32. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
33. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?
Naeim A; Keeler EB
Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407
[TBL] [Abstract][Full Text] [Related]
34. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
[TBL] [Abstract][Full Text] [Related]
36. Impact of a scientific presentation on community treatment patterns for primary breast cancer.
Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Freeman J; Goodwin JS
J Natl Cancer Inst; 2006 Mar; 98(6):382-8. PubMed ID: 16537830
[TBL] [Abstract][Full Text] [Related]
37. Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.
Raji MA; Tamborello LP; Kuo YF; Ju H; Freeman JL; Zhang DD; Giordano SH; Goodwin JS
Med Oncol; 2009 Dec; 26(4):452-9. PubMed ID: 19067255
[TBL] [Abstract][Full Text] [Related]
38. Defining care provided for breast cancer based on medical record review or Medicare claims: information from the Centers for Disease Control and Prevention Patterns of Care Study.
Fleming ST; Kimmick GG; Sabatino SA; Cress RD; Wu XC; Trentham-Dietz A; Huang B; Hwang W; Liff JM;
Ann Epidemiol; 2012 Nov; 22(11):807-13. PubMed ID: 22948184
[TBL] [Abstract][Full Text] [Related]
39. Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
Sathiakumar N; Delzell E; Morrisey MA; Falkson C; Yong M; Chia V; Blackburn J; Arora T; Brill I; Kilgore ML
Breast Cancer Res Treat; 2012 Jan; 131(1):231-8. PubMed ID: 21842243
[TBL] [Abstract][Full Text] [Related]
40. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer.
Du XL; Osborne C; Goodwin JS
J Clin Oncol; 2002 Dec; 20(24):4636-42. PubMed ID: 12488407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
